University Hospital of Cologne (Universitat zu Koln)
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Benzing, Thomas
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
NCT02923206: Proof-of-Concept Trial on Selective Removal of SFlt-1 in Pregnant Women with Preeclampsia Via Apheresis

Active, not recruiting
N/A
21
Europe
TheraSorb sFlt-1 adsorber
Miltenyi Biomedicine GmbH, Cromsource
Preeclampsia
07/25
12/25
AD(H)PKD, NCT02497521: The German ADPKD Tolvaptan Treatment Registry

Recruiting
N/A
2000
Europe
University of Cologne
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
11/25
12/27
FOrMe, NCT03949972: The Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Recruiting
N/A
500
Europe
Biosampling
Prof. Dr. Paul Brinkkoetter, German Research Foundation, Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
03/28
03/33

Download Options